| 103 |
Eda2r nik signaling pathway in muscle wasting
|
Kim Hyun Jun |
131 |
2023-06-21 |
|
| 102 |
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles
|
김선욱 |
352 |
2023-05-16 |
|
| 101 |
Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy
|
이상훈 |
115 |
2023-05-10 |
|
| 100 |
GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia
|
성현지 |
95 |
2023-05-10 |
|
| 99 |
PROX1 transcription factor controls rhabdomyosarcoma growth, stemness, myogenic properties and therapeutic targets
|
장은미 |
151 |
2023-04-07 |
|
| 98 |
The myokine Fibcd1 is an endogeneous determinant of myofiber size and mitigates cancer induced myofiber atrophy
|
Kim Hyun Jun |
107 |
2023-03-21 |
|
| 97 |
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target
|
성현지 |
122 |
2023-03-15 |
|
| 96 |
Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth f
|
김준형 |
113 |
2023-03-15 |
|
| 95 |
Cancer-Induced Muscle Wasting Requires p38b MAPK Activation of p300
|
김선욱 |
89 |
2023-02-23 |
|
| 94 |
Progression and Differentiation of Alveolar Rhabdomyosarcoma Is Regulated by PAX7 Transcription Factor—Significance of Tumor Subclones
|
장은미 |
74 |
2023-02-01 |
|
